Finance

Lists
Why is 688192 up 3.92%?
Dive Deeper
688192:SHA
Dizal Pharmaceutical Co Ltd
CNÂ¥58.01
+3.92%
(+2.19) 1D
Sep 30, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688192...
Open
CNÂ¥57.30
High
CNÂ¥60.00
Low
CNÂ¥55.57
Mkt. cap
26.98B
Avg. vol.
5.53M
Volume
8.29M
52-wk high
CNÂ¥73.50
52-wk low
CNÂ¥35.73
EPS
-CNÂ¥1.29
No. of employees
990
Open
CNÂ¥57.30
High
CNÂ¥60.00
Low
CNÂ¥55.57
Mkt. cap
26.98B
Avg. vol.
5.53M
Volume
8.29M
52-wk high
CNÂ¥73.50
52-wk low
CNÂ¥35.73
EPS
-CNÂ¥1.29
No. of employees
990
News stories
From web sources and news partners
marketscreener.com
marketscreener.com
·
1 hour ago
Can Treasuries rally for a second day?
ChartMill
ChartMill
·
10 hours ago
What's going on in today's session: S&P500 movers
Action Forex
Action Forex
·
1 hour ago
Elliott Wave Outlook: DOW Futures (Ym) Bearish Sequence Targets 49570
Investor's Business Daily
Investor's Business Daily
·
5 hours ago
Twilio To Join S&P 500 Index
About Dizal Pharmaceutical Co Ltd
CEO-
Employees990
FoundedOct 27, 2017
Headquarters-
SectorBiotechnology
Websitedizalpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
231.30M
214.83M
252.52M
270.17M
Cost of goods sold
9.70M
8.90M
10.29M
10.60M
Cost of revenue
9.70M
8.90M
10.29M
10.60M
Research and development expenses
235.97M
211.37M
187.80M
214.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
201.88M
190.93M
158.81M
160.08M
Operating expense
395.84M
447.15M
338.22M
381.36M
Total operating expenses
405.54M
456.05M
348.51M
391.96M
Operating income
-174.24M
-241.22M
-95.99M
-121.79M
Other non operating income
-894.53K
3.23M
180.03K
-218.18K
EBT including unusual items
-203.91M
-184.23M
-96.34M
-116.12M
EBT excluding unusual items
-180.55M
-248.71M
-103.12M
-130.21M
Income tax expense
-
1.34M
359.90K
273.39K
Effective tax rate
-
-0.73%
-0.37%
-0.24%
Other operating expenses
-42.46M
44.68M
-8.66M
6.65M
Net income
-202.59M
-184.10M
-95.56M
-114.82M
Net profit margin
-87.59%
-85.69%
-37.84%
-42.50%
Earnings per share
-
-
-
-
Interest and investment income
381.37K
295.52K
287.49K
251.42K
Interest expense
-6.44M
-10.01M
-7.60M
-8.90M
Net interest expenses
-6.06M
-9.71M
-7.31M
-8.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
-164.34M
-230.35M
-85.12M
-105.97M
Gain or loss from assets sale
279.00
-279.00
-
-84.07K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps